Linagliptin Metformin Spirig HC 2
Linagliptin Metformin Spirig HC 2 is a medicine authorised by Swissmedic under authorisation number 70591. The authorisation holder is Spirig HealthCare AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 24 June 2026 and the authorisation is limited until 23 June 2031. ATC code A10BD11 places the medicine in the group Drugs used in diabetes.
| Authorisation number | 70591 |
|---|---|
| Name | Linagliptin Metformin Spirig HC 2 |
| Full name | Linagliptin Metformin Spirig HC 2,5 / 500 mg, Filmtabletten |
| Authorisation holder | Spirig HealthCare AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | A10BD11 |
| First authorisation | 24 June 2026 |
| Authorisation validity | 23 June 2031 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Linagliptin Metformin Spirig HC 2,5 / 500 mg, Filmtabletten | B | 24 June 2026 |
| 2 | Linagliptin Metformin Spirig HC 2,5 / 850 mg, Filmtabletten | B | 24 June 2026 |
| 3 | Linagliptin Metformin Spirig HC 2,5 / 1000 mg, Filmtabletten | B | 24 June 2026 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 60 | Tablette(n) | A10BD11 | 07.06.2. | B |
| 2 | 180 | Tablette(n) | A10BD11 | 07.06.2. | B |
| 3 | 60 | Tablette(n) | A10BD11 | 07.06.2. | B |
| 4 | 180 | Tablette(n) | A10BD11 | 07.06.2. | B |
| 5 | 60 | Tablette(n) | A10BD11 | 07.06.2. | B |
| 6 | 180 | Tablette(n) | A10BD11 | 07.06.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Linagliptin Metformin Spirig HC 2 authorised in Switzerland?
Yes. Linagliptin Metformin Spirig HC 2 is authorised by Swissmedic under authorisation number 70591, data as of 01 September 2026. The authorisation is limited until 23 June 2031.
Which dispensing category does Linagliptin Metformin Spirig HC 2 have?
Linagliptin Metformin Spirig HC 2 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Linagliptin Metformin Spirig HC 2?
The authorisation holder is Spirig HealthCare AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.